Abstract
Uveodermatological syndrome is a widely recognised disease that continues to raise significant concern among both veterinarians and pet owners. Its aetiology, although still unclear, is believed to involve an autoimmune origin and genetic predisposition. The most common clinical signs include skin depigmentation, alopecia, poliosis, and, most frequently, granulomatous panuveitis. Affected dogs often develop secondary complications owing to persistent intraocular inflammation, such as cataracts and glaucoma. Although immunosuppressive therapy often yields a favourable response, recurrence is commonly observed. In some cases, uveodermatological syndrome presents a clinical challenge, as patients may experience adverse effects from medications, without which irreversible blindness may ensue.